Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer

Por Péron, J, Roy, P, Ding, K, Parulekar, W R, Roche, L, Buyse, M
Publicado no Br J Cancer (2015)

Leptin secretion and leptin receptor in the human stomach

Por Sobhani, I, Bado, A, Vissuzaine, C, Buyse, M, Kermorgant, S, Laigneau, J, Attoub, S, Lehy, T, Henin, D, Mignon, M, Lewin, M
Publicado em 2000

Designing phase II trials in cancer: a systematic review and guidance

Por Brown, S R, Gregory, W M, Twelves, C J, Buyse, M, Collinson, F, Parmar, M, Seymour, M T, Brown, J M
Publicado em 2011

Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC).

Por Gérard, A, Buyse, M, Nordlinger, B, Loygue, J, Pène, F, Kempf, P, Bosset, J F, Gignoux, M, Arnaud, J P, Desaive, C
Publicado em 1988

Two or Three Year Disease Free Survival (DFS) as a Primary Endpoint in Stage III Adjuvant Colon Cancer Trials with fluoropyrimidines with or without Oxaliplatin or Irinotecan: Data...

Por Sargent, D, Shi, Q, Yothers, G, Van Cutsem, E, Cassidy, J, Saltz, L, Wolmark, N, Bot, B, Grothey, A, Buyse, M, de Gramont, A
Publicado em 2011

Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer

Por Gill, S., Berry, S., Biagi, J., Butts, C., Buyse, M., Chen, E., Jonker, D., Mărginean, C., Samson, B., Stewart, J., Thirlwell, M., Wong, R., Maroun, J.A.
Publicado em 2011

Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.

Por Pezzella, F., Pastorino, U., Tagliabue, E., Andreola, S., Sozzi, G., Gasparini, G., Menard, S., Gatter, K. C., Harris, A. L., Fox, S., Buyse, M., Pilotti, S., Pierotti, M., Rilke, F.
Publicado em 1997

Gene expression profiling in breast cancer challenges the existence of intermediate histological grade

Por Sotiriou, C, Wirapati, P, Loi, S, Harris, A, Bergh, J, Smeds, J, Praz, V, Farmer, P, Haibe-Kains, B, Lallemand, F, Buyse, M, Piccart, M, Delorenzi, M
Publicado no Breast Cancer Res (2005)

The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?

Por Sobrero, A, Grothey, A, Iveson, T, Labianca, R, Yoshino, T, Taieb, J, Maughan, T, Buyse, M, André, T, Meyerhardt, J, Shields, A F, Souglakos, I, Douillard, J -Y, Cervantes, A
Publicado no Ann Oncol (2018)

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer:...

Por Malorni, L, Curigliano, G, Minisini, A M, Cinieri, S, Tondini, C A, D’Hollander, K, Arpino, G, Bernardo, A, Martignetti, A, Criscitiello, C, Puglisi, F, Pestrin, M, Sanna, G, Moretti, E, Risi, E, Biagioni, C, McCartney, A, Boni, L, Buyse, M, Migliaccio, I, Biganzoli, L, Di Leo, A
Publicado no Ann Oncol (2018)

Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective

Por Oza, A.M., Castonguay, V., Tsoref, D., Diaz–Padilla, I., Karakasis, K., Mackay, H., Welch, S., Weberpals, J., Hoskins, P., Plante, M., Provencher, D., Tonkin, K., Covens, A., Ghatage, P., Gregoire, J., Hirte, H., Miller, D., Rosen, B., Maroun, J., Buyse, M., Coens, C., Brady, M.F., Stuart, G.C.E.
Publicado em 2011

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.

Por Aabo, K., Adams, M., Adnitt, P., Alberts, D. S., Athanazziou, A., Barley, V., Bell, D. R., Bianchi, U., Bolis, G., Brady, M. F., Brodovsky, H. S., Bruckner, H., Buyse, M., Canetta, R., Chylak, V., Cohen, C. J., Colombo, N., Conte, P. F., Crowther, D., Edmonson, J. H., Gennatas, C., Gilbey, E., Gore, M., Guthrie, D., Yeap, B. Y.
Publicado em 1998

Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients

Por Haibe-Kains, B., Desmedt, C., Di Leo, A., Azambuja, E., Larsimont, D., Selleslags, J., Delaloge, S., Duhem, C., Kains, J.P., Carly, B., Maerevoet, M., Vindevoghel, A., Rouas, G., Lallemand, F., Durbecq, V., Cardoso, F., Salgado, R., Rovere, R., Bontempi, G., Michiels, S., Buyse, M., Nogaret, J.M., Qi, Y., Symmans, F., Pusztai, L., D'Hondt, V., Piccart-Gebhart, M., Sotiriou, C.
Publicado no Genom Data (2013)

Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population(†)

Por Renfro, L. A., Grothey, A., Kerr, D., Haller, D. G., André, T., Van Cutsem, E., Saltz, L., Labianca, R., Loprinzi, C. L., Alberts, S. R., Schmoll, H., Twelves, C., Yothers, G., Sargent, D. J., Sargent, D.J., Green, E., Grothey, A., Alberts, S.R., Shi, Q., Renfro, L.A., Yothers, G., O'Connell, M.J., Wolmark, N., de Gramont, A., Gray, R., Kerr, D., Haller, D.G., Guthrie, K., Buyse, M., Labianca, R., Seitz, J.F., O'Callaghan, C.J., Francini, G., Catalano, P.J., Blanke, C.D., Andre, T., Goldberg, R.M., Benson, A., Twelves, C., Sirzen, F., Cisar, L., Van Cutsem, E., Saltz, L.
Publicado no Ann Oncol (2015)